#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Frontotemporal dementia Congenital ectodermal dysplasia Waldenstrom's macroglobulinaemia Pancreatic neuroendocrine tumour Neuroendocrine tumour of the lung Microvillous inclusion disease Guillain-Barre syndrome Peritoneal mesothelioma malignant Neurofibroma Fibrodysplasia ossificans progressiva Penile cancer Waldenstrom's macroglobulinaemia refractory Oesophageal atresia Cold type haemolytic anaemia Necrotising enterocolitis neonatal More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Basic Information Paroxysmal nocturnal haemoglobinuria – Life with Disease Epidermolysis bullosa – Treatment Glomerulonephritis membranoproliferative – Basic Information Mastocytosis – Treatment Congenital nephrogenic diabetes insipidus – Diagnostics Ocular melanoma – Basic Information Activated PI3 kinase delta syndrome – Diagnostics Advanced systemic mastocytosis – Basic Information Burkitt’s lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tiaprofenic Acid Somatropin Zetomipzomib Ict01 Prednisone Df6002 Nebivolol Hydrochloride Eptacog Alfa (Activated) Ngi226 Morphine Hydrochloride Rosuvastatin Tramadol Hydrochloride Sertraline Hydrochloride Atacicept Azithromycin Plerixafor Basiliximab Aticaprant Milnacipran Hydrochloride Lepidoglyphus Destructor More therapies…

    Learn about Your Condition

    B-cell lymphoma Familial mediterranean fever Habitual abortion Lung adenocarcinoma stage III Chondropathy Herpes simplex meningitis Hypereosinophilic syndrome Retinopathy proliferative Diphtheria Cold type haemolytic anaemia Bacterial prostatitis Lichen sclerosus Myocarditis post infection Meniscus operation Metastatic glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study on Reducing Bleomycin Dose in Electrochemotherapy for Patients with Skin Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Bleomycin
    Denmark

  • Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Emavusertib
    • Ibrutinib
    Czechia France Italy Poland Spain

  • Study on Rituximab for Preventing Epstein-Barr Virus Infection and Lymphoproliferative Disorders in EBV-Negative Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    • Renal transplant
    Investigated Drugs:
    • Rituximab
    France

  • Study on ATX-01 for Adults Aged 18-64 with Myotonic Dystrophy Type 1 (DM1)

    Recruiting

    1 1
    Investigated Drugs:
    • 16-Base Single Stranded Rna Targeting Mir-23B Linked To Oleic Acid
    France Italy The Netherlands Spain

  • Study on Trabectedin for Adults and Young Adults with Advanced Mesenchymal Chondrosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chondrosarcoma
    • Chondrosarcoma metastatic
    Investigated Drugs:
    • Trabectedin
    Italy
Previous Page
1 … 516 517 518 519 520 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!